Critical elements in the development of cell therapy potency assays for ischemic conditions

Cytotherapy
Yael PoratClaudia Zylberberg

Abstract

A successful potency assay for a cell therapy product (CTP) used in the treatment of ischemic conditions should quantitatively measure relevant biological properties that predict therapeutic activity. This is especially challenging because of numerous degrees of complexity stemming from factors that include a multifactorial complex mechanism of action, cell source, inherent cell characteristics, culture method, administration mode and the in vivo conditions to which the cells are exposed. The expected biological function of a CTP encompasses complex interactions that range from a biochemical, metabolic or immunological activity to structural replacement of damaged tissue or organ. Therefore, the requirements for full characterization of the active substance with respect to biological function could be taxing. Moreover, the specific mechanism of action is often difficult to pinpoint to a specific molecular entity; rather, it is more dependent on the functionality of the cellular components acting in a in a multifactorial fashion. In the case of ischemic conditions, the cell therapy mechanism of action can vary from angiogenesis, vasculogenesis and arteriogenesis that may activate different pathways and clinical outcomes. The CTP...Continue Reading

References

May 4, 1999·The Journal of Clinical Investigation·J M Isner, T Asahara
Sep 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paolo MadedduCesare Peschle
Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Apr 28, 2006·Statistics in Medicine·UNKNOWN Committee for Medicinal Products for Human UseUNKNOWN Committee for Release for Consultation
Mar 27, 2007·Clinical and Experimental Nephrology·Masamichi EguchiTakayuki Asahara
Jan 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jochen TillmannsPiero Anversa
Apr 3, 2008·Asian Cardiovascular & Thoracic Annals·Kitipan V AromVibul Jotisakulratana
Aug 6, 2008·Journal of Leukocyte Biology·Melany C van OostromImo E Hoefer
Aug 8, 2008·Acta Biochimica Et Biophysica Sinica·Weijun Cai, Wolfgang Schaper
Aug 30, 2008·Journal of Molecular and Cellular Cardiology·Kentaro JujoDouglas W Losordo
Jan 27, 2009·Journal of Cellular Physiology·Rosendo EstradaEugenia Wang
Feb 11, 2010·Microvascular Research·Jörn TongersDouglas W Losordo
Aug 23, 2011·The International Journal of Developmental Biology·Anca-Maria CimpeanMarius Raica
Oct 4, 2012·Developmental Biology·Domenico Ribatti, Enrico Crivellato
Nov 30, 2012·Circulation. Cardiovascular Interventions·Douglas W LosordoUNKNOWN Autologous CD34+ Cell Therapy for Critical Limb Ischemia Investigators

❮ Previous
Next ❯

Citations

Jul 8, 2016·Stem Cells Translational Medicine·Carl G SimonAnne L Plant
Dec 16, 2020·ACS Biomaterials Science & Engineering·Deepika AroraCarl G Simon
Nov 12, 2017·Trends in Biotechnology·Ross A MarkleinSteven R Bauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.